ADAR1 Antibody [E16C6]

Catalog No.: F7867

Application: Reactivity: Human, Monkey

Lane 1: HepG2, Lane 2: Vero

当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

代表番号: 045-509-1970|電子メール：sales@selleck.co.jp

使用情報

Dilution
WB1:1000

Application
WB

Source
Rabbit Monoclonal Antibody

Reactivity
Human, Monkey

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
110 kDa, 150 kDa

Datasheet & SDS

生物学的記述

Specificity
ADAR1 Antibody [E16C6] detects endogenous levels of total ADAR1 protein.

Clone
E16C6

Synonym(s)
Double-strand adenosine deaminase; DRADA; 136 kDa double-stranded RNA-binding protein (p136); Interferon-inducible protein 4 (IFI-4); K88DSRBP; ADAR; ADAR1; DSRAD; G1P1; IFI4

Background
ADAR1 (adenosine deaminase acting on RNA 1) is a double‑stranded RNA‑specific adenosine deaminase that belongs to the ADAR family and catalyzes the conversion of adenosine to inosine (A‑to‑I editing) in structured RNA regions, a process that is interpreted as an A‑to‑G change by the splicing and translational machinery and thereby diversifies transcript and protein isoforms without altering the genomic sequence. It exists as two major isoforms, ADAR1L (p150) and ADAR1S (p110), generated from alternative promoters and translation start sites, with ADAR1S localized constitutively in the nucleus and ADAR1L being inducible by interferon and present in both the nucleus and the cytoplasm, where it can engage overlapping but non‑identical substrate pools. ADAR1‑mediated editing modulates sequence recognition by RNA‑binding proteins and non‑coding RNAs, including microRNAs, and thereby influences alternative splicing, mRNA stability, translational efficiency, and the targeting of regulatory RNAs. ADAR1 functions as a key suppressor of aberrant interferon responses by editing endogenous double‑stranded RNAs so that they are not recognized as foreign by cytoplasmic RNA sensors such as MDA5 and RIG‑I; loss or inhibition of ADAR1 leads to accumulation of unedited or hyperedited substrates that trigger type‑I and type‑II interferon signaling and inflammation. ADAR1 is also essential for their maintenance in the fetal liver and adult bone marrow, and ADAR1 deficiency in these cells causes global upregulation of interferon‑stimulated genes and rapid apoptosis.

Background

ADAR1 (adenosine deaminase acting on RNA 1) is a double‑stranded RNA‑specific adenosine deaminase that belongs to the ADAR family and catalyzes the conversion of adenosine to inosine (A‑to‑I editing) in structured RNA regions, a process that is interpreted as an A‑to‑G change by the splicing and translational machinery and thereby diversifies transcript and protein isoforms without altering the genomic sequence. It exists as two major isoforms, ADAR1L (p150) and ADAR1S (p110), generated from alternative promoters and translation start sites, with ADAR1S localized constitutively in the nucleus and ADAR1L being inducible by interferon and present in both the nucleus and the cytoplasm, where it can engage overlapping but non‑identical substrate pools. ADAR1‑mediated editing modulates sequence recognition by RNA‑binding proteins and non‑coding RNAs, including microRNAs, and thereby influences alternative splicing, mRNA stability, translational efficiency, and the targeting of regulatory RNAs. ADAR1 functions as a key suppressor of aberrant interferon responses by editing endogenous double‑stranded RNAs so that they are not recognized as foreign by cytoplasmic RNA sensors such as MDA5 and RIG‑I; loss or inhibition of ADAR1 leads to accumulation of unedited or hyperedited substrates that trigger type‑I and type‑II interferon signaling and inflammation. ADAR1 is also essential for their maintenance in the fetal liver and adult bone marrow, and ADAR1 deficiency in these cells causes global upregulation of interferon‑stimulated genes and rapid apoptosis.

References
[1] Hartner JC, et al. Nat Immunol. 2009 May;10(5):551. [2] Mannion NM, et al. Cell Rep. 2014 Nov 20;9(4):1482-94.

PVDFメンブレン孔径参考表

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%